Alle Storys
Folgen
Keine Story von LifeWatch AG mehr verpassen.

LifeWatch AG

EANS-Adhoc: LifeWatch is notified that previously announced revised reimbursement rate will be implemented on September 1 Highmark remains willing to review further clinical information

  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
  distribution. The issuer is solely responsible for the content of this
  announcement.
01.09.2009
Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss 
Exchange: LIFE), the leading provider of wireless cardiac monitoring 
services in the U.S., was notified by Highmark Medicare Services 
(HMS) that the proposed lower reimbursement rate for wireless cardiac
monitoring services will be implemented on September 1, 2009, as 
previously announced for all Medicare/Medicaid-covered contracts.
Highmark Medicare Services also indicated that they remain open to 
review any further clinical information made available to them 
"within reasonable time" and that "any further adjustment to the 
allowance will be made, as appropriate".
In addition to the information LifeWatch has already provided to 
Highmark, the Company and the coalition of Independent Diagnostic 
Testing Facilities (IDTFs) will continue to compile and submit 
further information to demonstrate that the revised reimbursement 
rate is inappropriately low.
LifeWatch will inform the public on any important new developments.
end of ad-hoc-announcement
About LifeWatch AG
LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss
Exchange (LIFE), Switzerland, is the leading healthcare technology 
and solution company, specializing in advanced telehealth systems and
wireless cardiac monitoring services. LifeWatch services treat 
high-risk and chronically ill patients, health conscious consumers 
and wellness programs. LifeWatch has subsidiaries in the United 
States, the Netherlands, Japan, the United Kingdom, Switzerland and 
Israel. LifeWatch AG is the parent company of LifeWatch Services 
Inc., a leading US-based cardiac monitoring service provider, and 
manufacturer of telecardiology products. www.lifewatch.com
Sign-up for customized e-mail alerts and documentation requests is 
available at http://production.investis.com/lifewatch/alert-service/
This press release includes forward-looking statements. All 
statements other than statements of historical facts contained in 
this press release, including statements regarding future results of 
operations and financial position, business strategy and plans and 
objectives for future operations, are forward-looking statements. The
words "believe," "may," "will," "estimate," "continue," "anticipate,"
"intend," "expect" and similar expressions are intended to identify 
forward-looking statements. LifeWatch AG has based these forward 
looking statements largely on current expectations and projections 
about future events and financial trends that it believes may affect 
the financial condition, results of operations, business strategy, 
short term and long term business operations and objectives, and 
financial needs. These forward-looking statements are subject to a 
number of risks, uncertainties and assumptions. In light of these 
risks, uncertainties and assumptions, the forward-looking events and 
circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the 
forward-looking statements. All forward-looking statements are based 
only on data available to LifeWatch AG at the time of the issue of 
this press release. LifeWatch AG does not undertake any obligation to
update any forward- looking statements contained in this press 
release as a result of new information, future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF 
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR 
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS 
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN 
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH 
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE 
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN 
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE 
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. 
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY 
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG 
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED 
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL 
STATEMENTS OF THE ISSUER.
end of announcement                               euro adhoc

Further inquiry note:

For further information from LifeWatch please contact:

Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG
Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | E-mail kobibe@lifewatch.com

Sensus Investor & Public Relations GmbH, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.ch

Westwicke Partners LLC
Tel +1 443 213 0500 | Fax +1 410 415 5268 | E-mail asher.dewhurst@westwicke.com

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / free trade

Weitere Storys: LifeWatch AG
Weitere Storys: LifeWatch AG